Innovations in regenerative medicine and stem cell therapy for diabetes offer hope for restoring insulin production and reversing disease progression. Stem cell-derived beta-cell transplants are being developed to replace damaged pancreatic cells, providing a potential cure for type 1 diabetes. Advances in tissue engineering and gene editing technologies, such as CRISPR, enable the creation of personalized regenerative therapies. Encapsulation techniques protect transplanted cells from immune attack, enhancing long-term viability. While challenges remain in achieving sustained insulin secretion and immune tolerance, ongoing clinical trials are bringing regenerative medicine closer to clinical application. These breakthroughs could revolutionize diabetes treatment, reducing dependence on insulin therapy
Mahir Khalil Ibrahim Jallo
Gulf Medical University, Canada
Yong Xiao Wang
Albany Medical College, United States
F Buck Willis
University of Belize, Belize
Sujith Rajan
NYU Long Island School of Medicine, United States
Amy Gutman
AdventHealth; Tough Love MD, United States
Paraskevi Theofilou
Hellenic Open University, Greece
Teji S Dhami
Boost your Health and Wellness, United StatesSubmit your abstract Today
Title : Adipose MTP deficiency protects against hepatic steatosis by upregulating PPAR activity
Sujith Rajan, NYU Long Island School of Medicine, United States
Title : Important roles and mechanisms of novel calcium signaling in diabetes-induced vascular dementia
Yong Xiao Wang, Albany Medical College, United States
Title : Does winter melon (Benincasa hispida) improves nutritional values and ameliorating glycaemic parameters?
Wan Rosli Wan Ishak, Universiti Sains Malaysia, Malaysia
Title : Diabetes reduction (pre-diabetes and type 2) with integrative medicine
F Buck Willis, University of Belize, Belize
Title : Bridging the gap: Coaching patients on GLP-1s for sustainable outcomes beyond the prescription
Keith Hersey, Master Your GLP-1, United States
Title : The menopausal mind: Reframing female senescence as a neuroendocrine disorder with root cause management strategies
Amy Gutman, AdventHealth; Tough Love MD, United States